FDC

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE258B01022
  • NSEID: FDC
  • BSEID: 531599
INR
412.80
-1.05 (-0.25%)
BSENSE

Dec 05

BSE+NSE Vol: 15.71 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
1,121.44
1,152.12
1,022.74
939.65
845.09
679.57
689.64
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,121.44
1,152.12
1,022.74
939.65
845.09
679.57
689.64
Raw Material Cost
318.97
275.70
292.36
312.80
227.12
167.08
176.79
Purchase of Finished goods
68.19
68.85
62.87
47.85
94.38
52.95
42.98
(Increase) / Decrease In Stocks
-33.36
69.47
-3.21
-11.94
-38.37
-20.98
16.36
Employee Cost
253.16
242.16
206.65
196.51
181.20
143.02
137.14
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
338.89
279.15
265.65
249.11
194.09
128.20
164.03
Total Expenditure (Excl Depreciation)
945.85
935.33
824.32
794.33
658.42
470.27
537.30
Operating Profit (PBDIT) excl Other Income
175.59
216.79
198.42
145.32
186.67
209.30
152.34
Other Income
54.69
63.14
56.66
31.85
53.58
47.01
26.69
Operating Profit (PBDIT)
230.28
279.93
255.08
177.17
240.25
256.31
179.03
Interest
2.32
2.37
2.11
1.73
1.54
1.57
1.63
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
227.96
277.56
252.97
175.44
238.71
254.74
177.40
Depreciation
30.10
24.82
19.51
19.34
19.05
19.09
18.93
Profit Before Tax
197.86
252.73
233.47
156.11
219.67
235.65
158.47
Tax
48.14
61.65
53.86
33.65
49.51
55.87
47.70
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
149.72
191.08
179.60
122.45
170.16
179.78
110.77
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
149.72
191.08
179.60
122.45
170.16
179.78
110.77
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.02
-0.52
Minority Interest
0.00
0.00
0.11
0.12
0.11
0.02
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
149.72
191.08
179.71
122.58
170.27
179.83
110.25
Equity Capital
16.28
16.28
16.28
16.59
16.88
17.10
17.10
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
9.2
11.74
11.04
7.39
10.09
10.52
6.45
Diluted Earnings per share
9.2
11.74
10.84
7.35
10.08
10.52
6.41
Operating Profit Margin (Excl OI)
15.66%
18.82%
19.4%
15.47%
22.09%
30.8%
22.09%
Gross Profit Margin
20.33%
24.09%
24.73%
18.67%
28.25%
37.49%
25.72%
PAT Margin
13.35%
16.59%
17.56%
13.03%
20.14%
26.45%
16.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is -2.66% vs 12.65% in Sep 2024

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2025 is -21.65% vs 6.33% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is -19.00% vs 9.26% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is -2.11% vs 12.32% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has fallen from Sep 2024

Compare Half Yearly Results Of FDC With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,121.44
0
1,121.44
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,121.44
0
1,121.44
Raw Material Cost
318.97
0
318.97
Purchase of Finished goods
68.19
0
68.19
(Increase) / Decrease In Stocks
-33.36
0
-33.36
Employee Cost
253.16
0
253.16
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
338.89
0.00
338.89
Total Expenditure (Excl Depreciation)
945.85
0
945.85
Operating Profit (PBDIT) excl Other Income
175.59
0.00
175.59
Other Income
54.69
0
54.69
Operating Profit (PBDIT)
230.28
0
230.28
Interest
2.32
0
2.32
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
227.96
0
227.96
Depreciation
30.10
0
30.10
Profit Before Tax
197.86
0
197.86
Tax
48.14
0
48.14
Provisions and contingencies
0.00
0
0.00
Profit After Tax
149.72
0
149.72
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
149.72
0
149.72
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
149.72
0
149.72
Equity Capital
16.28
0
16.28
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
9.20
0
9.20
Diluted Earnings per share
9.20
0
9.20
Operating Profit Margin (Excl OI)
15.66%
0%
0.00
15.66%
Gross Profit Margin
20.33%
0%
0.00
20.33%
PAT Margin
13.35%
0%
0.00
13.35%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 1,121.44 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -2.66% vs 12.65% in Sep 2024

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 149.72 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -21.65% vs 6.33% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 175.59 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -19.00% vs 9.26% in Sep 2024

Half Yearly - Interest
Interest 2.32 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -2.11% vs 12.32% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.66%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has fallen from Sep 2024